14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $143.51 $159.34 Tuesday, 23rd Apr 2024 ALNY stock ended at $146.07. This is 0.192% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 3.20% from a day low at $145.61 to a day high of $150.27.
90 days $143.51 $191.72
52 weeks $143.51 $218.88

Historical Alnylam Pharmaceuticals prices

Date Open High Low Close Volume
Jul 07, 2023 $193.43 $195.98 $192.06 $192.68 284 024
Jul 06, 2023 $190.37 $194.94 $190.08 $194.39 407 548
Jul 05, 2023 $190.00 $194.40 $189.06 $192.57 328 916
Jul 03, 2023 $188.43 $190.26 $187.65 $189.69 228 054
Jun 30, 2023 $193.83 $195.82 $189.02 $189.94 696 827
Jun 29, 2023 $195.32 $195.51 $190.80 $191.06 307 236
Jun 28, 2023 $189.32 $197.38 $188.78 $196.56 336 888
Jun 27, 2023 $190.54 $191.00 $187.86 $188.80 1 120 300
Jun 26, 2023 $192.19 $193.38 $188.77 $191.35 313 632
Jun 23, 2023 $196.71 $196.71 $191.82 $192.69 425 929
Jun 22, 2023 $203.31 $203.31 $199.04 $199.07 482 435
Jun 21, 2023 $201.20 $204.56 $200.54 $203.90 369 159
Jun 20, 2023 $199.31 $202.31 $198.20 $201.60 646 628
Jun 16, 2023 $203.70 $205.25 $201.03 $201.57 692 147
Jun 15, 2023 $197.87 $202.88 $196.77 $202.34 295 230
Jun 14, 2023 $197.91 $200.06 $195.77 $198.49 596 137
Jun 13, 2023 $193.23 $198.34 $193.23 $197.54 411 894
Jun 12, 2023 $192.74 $193.18 $188.80 $193.09 355 363
Jun 09, 2023 $190.65 $192.93 $189.68 $190.83 366 172
Jun 08, 2023 $190.22 $192.73 $190.10 $190.43 325 747
Jun 07, 2023 $192.08 $192.40 $188.09 $190.17 345 192
Jun 06, 2023 $192.68 $194.86 $191.15 $192.96 263 184
Jun 05, 2023 $192.96 $195.19 $191.78 $192.30 294 173
Jun 02, 2023 $190.88 $195.80 $188.81 $193.67 344 188
Jun 01, 2023 $185.81 $189.57 $184.07 $188.67 370 528
Click to get the best stock tips daily for free!

About Alnylam Pharmaceuticals

Alnylam Pharmaceuticals Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system (CNS)/ocular diseases. Its marketed products include ONPATTRO (patisiran), a lipid complex injection f... ALNY Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT